Skip to main content

Table 1 LncRNAs and their mechanisms in HCC suppression and promotion

From: Modulation of the TGF-β signaling pathway by long noncoding RNA in hepatocellular carcinoma

LncRNAs

Effect

Mechanism

Downstream Pathway

BZRAP1-AS1

Oncogene

Epigenetic modification

DNMT3b/THBS1

PVT1

Oncogene

Epigenetic modification

EZH2/MYC

Linc-GALH

Oncogene

Epigenetic modification

DNMT1/Gankyrin

DLX6-AS1

Tumor suppressor

Epigenetic modification

CADM1/Stat3

Linc00467

Oncogene

CeRNA

miR-509-3p/PDGFRA

Linc00346

Oncogene

CeRNA

miR-199a-3p/CDK1,CCNB1

HULC

Oncogene

CeRNA

miR-675/PKM2

  

CeRNA

miR-2052/MET

RP11-422 N16.3

Tumor suppressor

CeRNA

miR-23b-3p/DMGDH

MALAT1

Oncogene

CeRNA

miR-140/VEGFA

  

Alterative Splicing

SRSF1/S6K1

HAND2-AS1

Oncogene

Binding to proteins

INO80/BMPR1A

Linc00324

Oncogene

Binding to proteins

PU.1/FASL

Linc01093

Tumor suppressor

Binding to proteins

IGF2BP1/GLI1

SLC2A1-AS1

Tumor suppressor

Binding to proteins

STAT3/FOXM1/GLUT1

PCNA1-AS1

Oncogene

Antisense

PCNA1

LncHOXA10

Oncogene

Antisense

HOXA10

  1. BZRAP1-AS1 benzodiazapine receptor associated protein 1 antisense RNA 1; DNMT3b DNA methyltransferase 3B; THBS1 thrombospondin-1; PVT1 plasmacytoma variant translocation 1; HULC highly upregulated in liver cancer; Malat1, metastasis-associated lung adenocarcinoma transcript 1; HAND2 heart and neural crest derivatives-expressed transcript 2; DMGDH Dimethylglycine dehydrogenase; GLUT1 Glucose transporter type 1; FOXM1 Forkhead box protein M1